CARULLI, Lucia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 18.312
AS - Asia 6.914
EU - Europa 6.038
SA - Sud America 931
Continente sconosciuto - Info sul continente non disponibili 202
AF - Africa 158
OC - Oceania 22
Totale 32.577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 17.903
SG - Singapore 2.333
CN - Cina 1.729
GB - Regno Unito 1.581
IT - Italia 1.259
HK - Hong Kong 849
BR - Brasile 711
DE - Germania 640
VN - Vietnam 625
SE - Svezia 493
FI - Finlandia 388
PL - Polonia 371
UA - Ucraina 345
BD - Bangladesh 321
FR - Francia 265
RU - Federazione Russa 265
TR - Turchia 250
CA - Canada 195
KR - Corea 141
IN - India 139
BG - Bulgaria 114
ID - Indonesia 77
IQ - Iraq 73
AR - Argentina 72
MX - Messico 62
JP - Giappone 59
NL - Olanda 49
PK - Pakistan 44
IE - Irlanda 40
AE - Emirati Arabi Uniti 39
ES - Italia 36
BE - Belgio 33
ZA - Sudafrica 31
CO - Colombia 30
EC - Ecuador 30
CR - Costa Rica 29
MA - Marocco 29
TW - Taiwan 29
AT - Austria 28
VE - Venezuela 27
MY - Malesia 26
HN - Honduras 23
PH - Filippine 22
CL - Cile 21
SA - Arabia Saudita 21
CZ - Repubblica Ceca 18
UZ - Uzbekistan 18
KE - Kenya 17
AU - Australia 16
IR - Iran 16
CH - Svizzera 15
SV - El Salvador 15
DZ - Algeria 14
IL - Israele 14
JM - Giamaica 14
PY - Paraguay 14
SC - Seychelles 14
NI - Nicaragua 13
TT - Trinidad e Tobago 13
EG - Egitto 12
ET - Etiopia 12
JO - Giordania 12
LT - Lituania 11
RO - Romania 11
GT - Guatemala 10
NO - Norvegia 10
PE - Perù 10
AZ - Azerbaigian 9
BO - Bolivia 9
NP - Nepal 9
OM - Oman 9
PA - Panama 9
AL - Albania 8
CW - ???statistics.table.value.countryCode.CW??? 8
DK - Danimarca 7
GP - Guadalupe 7
PR - Porto Rico 7
TH - Thailandia 7
BY - Bielorussia 6
GE - Georgia 6
KG - Kirghizistan 6
SI - Slovenia 6
TN - Tunisia 6
UY - Uruguay 6
AM - Armenia 5
BA - Bosnia-Erzegovina 5
EU - Europa 5
HU - Ungheria 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
RS - Serbia 5
BF - Burkina Faso 4
DO - Repubblica Dominicana 4
GR - Grecia 4
PS - Palestinian Territory 4
PT - Portogallo 4
UG - Uganda 4
BB - Barbados 3
EE - Estonia 3
HR - Croazia 3
Totale 32.339
Salva come PNG Salva come JPEG
Città #
Ashburn 2.402
Singapore 1.601
Fairfield 1.379
Santa Clara 1.338
Southend 978
Hong Kong 837
San Jose 790
Woodbridge 759
Houston 740
Chandler 697
Jacksonville 551
Chicago 544
Seattle 478
Wilmington 469
Cambridge 466
Council Bluffs 459
Los Angeles 422
Dearborn 417
Ann Arbor 408
Hefei 355
Warsaw 354
Beijing 343
Nyköping 319
London 287
Helsinki 266
Modena 235
Salt Lake City 211
New York 195
Ho Chi Minh City 189
The Dalles 172
San Diego 159
Hanoi 154
Izmir 134
Munich 130
Seoul 129
Princeton 128
Tampa 115
Sofia 111
Milan 110
Columbus 107
São Paulo 105
Eugene 101
Shanghai 98
Buffalo 94
Elk Grove Village 90
Lauterbourg 88
Dallas 84
Rome 65
Boardman 61
Phoenix 60
Fremont 54
Sterling 54
Moscow 52
Des Moines 50
Toronto 50
Lancaster 49
Bologna 46
Jakarta 46
Washington 46
North Bergen 44
Frankfurt am Main 40
Guangzhou 40
Baghdad 39
Orem 38
Redwood City 38
Brooklyn 36
Tokyo 36
Montreal 34
Turku 33
Detroit 32
Dublin 32
Mexico City 32
Atlanta 30
Broomfield 30
San Francisco 30
Brussels 29
Miami 29
Dulles 27
Falls Church 26
Bremen 25
Denver 24
Haiphong 24
Da Nang 23
Kunming 23
Chennai 22
San Mateo 22
Manchester 21
Naples 21
Dongguan 20
Parma 20
Bari 19
Boston 19
Norwalk 19
Amsterdam 18
Kansas City 18
Philadelphia 18
Zhengzhou 18
Dhaka 17
Hounslow 17
Nuremberg 17
Totale 22.331
Salva come PNG Salva come JPEG
Nome #
ABCB4 and ABCB11 mutations in intrahepatic cholestasis of pregnancy in an Italian population 748
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 556
17 Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures 494
Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: A possible compensatory mechanism. 484
Gallstone disease in non-alcoholic fatty liver: Prevalence and associated factors 468
Age-related changes in bile acid synthesis and hepatic nuclear receptor expression 459
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 443
Gender, fatty liver and GGT 434
Changes in bile acid synthesis in gallstone disease: cause, consequence or neither? 434
Review article: diabetes, genetics and ethnicity 433
Decreased hepatic expression of PPAR-gamma coactivator-1 in cholesterol cholelithiasis. 427
APOE MODENA : A NOVEL APOE MUTANT CAUSING LIPOPROTEIN GLOMERULOPATHY 418
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 408
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 404
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 403
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 400
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 399
Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans 394
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 391
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 387
Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population. 383
Hepatic steatosis and insulin resistance: Does etiology make a difference? 377
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 375
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 371
Correlation between plasma levels of 7alpha-hydroxy-4-cholesten-3-one and cholesterol 7alpha-hydroxylation rates in vivo in hyperlipidemic patients 368
Telomere length elongation after weight loss intervention in obese adults 364
Genetic polymorphisms in non-alcoholic fatty liver disease: Interleukin-6-174G/C polymorphism is associated with non-alcoholic steatohepatitis 361
Endocrine and liver interaction: the role of endocrine pathways in NASH 360
Classical and innovative insulin sensitizing drugs for the prevention and treatment of NAFLD 357
In Vivo Degradation of Cholesterol to Bile Acids Is Reduced in Patients Receiving Parenteral Nutrition. 353
Non-organ-specific autoantibodies in nonalcoholic fatty liver disease: Prevalence and correlates 352
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 348
Bile acids and nonalcoholic fatty liver disease: An intriguing relationship 348
ESTIMATION OF CARDIOVASCULAR RISK IN TYPE 2 DIABETES 328
Regulation of ob gene expression: evidence for epinephrine-induced suppression in human obesity 326
Lung fibrosis, bone marrow fibrosis and liver cirrhosis: A Short Telomere Syndrome or a casual association? 323
Nuclear receptors as potential molecular targets in cholesterol accumulation conditions: Insights from evidence on hepatic cholesterol degradation and gallstone disease in humans 323
Review article: effect of bile salt pool composition on hepatic and biliary functions 318
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 315
INCREASED 27-HYDROXYLATION OF CHOLESTEROL IN PRIMARY HYPERCHOLESTEROLEMIA 314
Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomeres involvement on line pubblication 03-Oct-2012Hepatology- 314
Risk for cardiovascular events in an Italian population of patients with type 2 diabetes 310
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 309
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 303
HEPATIC EXPRESSION OF NUCLEAR RECEPTORS AND BILIARY TRANSPOTERS IN HUMAN CHOLESTEROL GALLSTONE DISEASE. 302
Telomere and telomerase in chronic liver disease and hepatocarcinoma 301
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 300
Hepatic nuclear receptors in human cholelithiasis: A link with insulin resistance? 300
The Individual Care Plan (ICP): proposal of a model to improve the communication between hospital and primary health care services 298
MOLECULAR REGULATION OF STEROL METABOLISM BY BILE ACIDS IN CULTURED HUMAN HEPATOCYTES 296
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 294
Olanzapine metabolic side effects: a weight gain issue? 291
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 290
Antiretroviral drugs induced metabolic diseases in HIV infected patients. 284
Nuclear receptors and obstructive cholestasis in Humans: increased heaptic expression of short heterodimer partner : a protective response? 283
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 276
Bleeding jejunal varices and portal thrombosis in a splenectomized patient with hereditary spherocytosis 270
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 269
Influence of age on bile acid synthesis: Role of hepatic expression of nuclear receptors 268
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 267
Genetic polymorphism PC-1 K121Q and ethnic susceptibility to insulin resistance. 264
Cholesterol metabolism in gallstone disease .Preliminary evidence from the analysis of circulating markers of sterol homeostasis 260
Regolazione della sintesi di colesterolo e acidi biliari 257
Olanzapine-induced hypertriglyceridemia and Diabetes mellitus 254
TYPE 2 DIABETES AND CARDIOVASCULAR EVENTS : STUDY OF THE AMIN RISK FACTORS IN A LOCAL POPULATION OF PATIENTS 252
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 249
The genetic basis of Insulin resistance. A brief review 248
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 246
Telomere shortening as genetic risk factor of liver cirrhosis 244
Gender differences in chronic alcoholic and viral liver diseases 242
RISK FOR CARDIOVASCULAR EVENTS IN AN ITALIAN POPULATION OF PATIENTS WITH TYPE 2 DIABETES 237
Fatty liver, carotid disease and gallstones: A study ofage-related associations 230
Increase degradation of cholesterol via the alternate pathway of bile acid biosynthesis in primary hypercholesterolemia. 228
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 227
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 227
Influence of newly synthesized cholesterol on bile acid synthesis during chronic inhibition of bile acid absorption 225
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 223
Invecchiamento e alterazioni dell’omeosatsi del colesterolo: studio dei livelli plasmatici degli steroli idrossilati come markers metabolici. 222
Cirrosi criptogenetiche. Un report di 5 pazienti 222
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 222
Telomeres and atherosclerosis 221
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 220
Tipologia dei ricoveri negli Ospedali Universitari: l'impatto sulle attività istituzionali 219
NAFLD AND TYPE 2 DIABETES: A GENETIC OR METABOLIC ISSUE? 217
Epidemiologia e storia naturale dell'epatopatia steatosica non alcolica 216
RISK FOR CARDIOVASCULAR EVENTS IN A LOCAL POPULATION OF DIABETIC PATIENTS 216
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 216
HEPATIC NUCLEAR RECEPTOR EXPRESSION AND REGULATION OF BILE ACID SYNTHESIS IN HUMANS 212
Cholestatic icterus: is there still a role for the clinic? 210
Reply 207
Structure and concentartion of differenty fatty acid (FFAS) affect steatosis extent and apoptosis in hepatocytes coltures 206
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 206
DIABETES AND CARDIOVASCULAR EVENTS: USEFULNESS AND LIMITS OF RISK FUNCTIONS 197
Invecchiamento ed alterazioni dell’omeostasi del colesterolo: studi dei livelli plasmatici degli steroli idrossilati come markers metabolici. 196
Risk for cardiovascular events in a local population of diabetic patients 193
Fatty liver disease associated with epatiti C and/or human immunodeficiency virus: characterization of the link between hepatic steatosis, insulin resistance and metabolic syndrome. 189
regulation of bile acid synthesis in humans: availability of newly sythetized cholesterol is a limiting fator during pharmacological inhibition of bile acid recirculation. 183
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 176
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 175
La calcolosi biliare. 174
Totale 30.601
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.140
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.624 0 0 0 0 64 115 182 147 282 133 421 280
2022/20231.970 220 203 170 197 211 312 42 173 248 15 78 101
2023/20241.332 55 71 86 91 253 134 209 165 26 31 65 146
2024/20254.606 120 56 87 322 944 705 304 236 431 213 489 699
2025/202610.494 470 305 606 1.317 2.613 1.022 1.086 404 837 787 583 464
2026/20273.408 264 554 756 1.622 212 0 0 0 0 0 0 0
Totale 32.577